U.S. Senator Tammy Duckworth of Illinois recently introduced a new bill aimed at forcing insurance companies to cover routine assisted reproductive technologies such as in vitro fertilization (IVF). If passed, this legislation would significantly reduce the out-of-pocket burden for infertility patients undergoing treatments such as IVF and embryo screening, giving more families the opportunity to fulfill their reproductive wishes through legal medical channels.
Under the current U.S. system, many insurance plans do not cover IVF-related costs, leaving patients to pay tens of thousands of dollars per treatment cycle. Senator Duckworth herself has undergone IVF treatment, and she emphasized that fertility medical care should not become a luxury affordable only to the wealthy. The bill requires that both employer-provided group insurance and the individual insurance market include at least three complete IVF cycles, as well as coverage for necessary genetic testing and medication costs.
The bill has also gained support from some fertility medicine experts. They point out that insurance coverage can encourage patients to seek professional help early, avoiding delays in treatment due to financial pressure. In addition, the bill specifically stipulates that insurance companies may not refuse coverage on the grounds of "pre-existing conditions," ensuring that all eligible patients can access fair medical resources.
For cross-border medical readers in Chinese-speaking regions, this bill reflects important progress in the United States regarding accessibility of fertility medical care. Although some fertility subsidies already exist in places such as Taiwan and Hong Kong, insurance coverage remains limited. If this bill passes, it could serve as a model for other countries to reference, prompting more regions to value public support for fertility medical care.
Senator Duckworth's proposal is not only a reflection of her personal experience, but also a major reform initiative for the U.S. fertility medical system. If it successfully becomes law in the future, it will help alleviate the financial pressure on infertility patients and enhance the overall fairness of fertility medical care.
This article was prepared with AI assistance and reviewed by our editorial team before publication.
This content is for informational purposes only and does not constitute medical advice. Please consult a licensed physician. Content guidelines & editorial policy
News | US Senator Duckworth pushes IVF insurance coverage bill
U.S. Senator Tammy Duckworth of Illinois recently introduced a new bill aimed at forcing insurance companies to cover routine assisted reproductive technologies such as in vitro fertilization (IVF). If passed, this legislation would significantly reduce the out-of-pocket burden for infertility patients undergoing treatments such as IVF and embryo screening, giving more families the opportunity to fulfill their reproductive wishes through legal medical channels.
Under the current U.S. system, many insurance plans do not cover IVF-related costs, leaving patients to pay tens of thousands of dollars per treatment cycle. Senator Duckworth herself has undergone IVF treatment, and she emphasized that fertility medical care should not become a luxury affordable only to the wealthy. The bill requires that both employer-provided group insurance and the individual insurance market include at least three complete IVF cycles, as well as coverage for necessary genetic testing and medication costs.
The bill has also gained support from some fertility medicine experts. They point out that insurance coverage can encourage patients to seek professional help early, avoiding delays in treatment due to financial pressure. In addition, the bill specifically stipulates that insurance companies may not refuse coverage on the grounds of "pre-existing conditions," ensuring that all eligible patients can access fair medical resources.
For cross-border medical readers in Chinese-speaking regions, this bill reflects important progress in the United States regarding accessibility of fertility medical care. Although some fertility subsidies already exist in places such as Taiwan and Hong Kong, insurance coverage remains limited. If this bill passes, it could serve as a model for other countries to reference, prompting more regions to value public support for fertility medical care.
Senator Duckworth's proposal is not only a reflection of her personal experience, but also a major reform initiative for the U.S. fertility medical system. If it successfully becomes law in the future, it will help alleviate the financial pressure on infertility patients and enhance the overall fairness of fertility medical care.
Source: U.S. Senator Tammy Duckworth (.gov). This article is a compiled report for general informational reference.